In lung cancer, two f-circRNAs derived from EML4::ALK fusion have been identified, and proposed as a liquid biopsy biomarker [19, 20], whereas another f-circRNA from SLC34A2::ROS1 translocation was proven to boost cancer cell migration [21]. The gene discussed is EML4; the disease is lung carcinoma.